Enterprise Innovation

Weill Cornell Medicine Enterprise Innovation translates the groundbreaking research of Weill Cornell Medicine faculty into breakthroughs in medical care. WCM Enterprise Innovation encompasses the entire spectrum of a healthy innovation ecosystem, combining the Office of BioPharma Alliances & Research Collaborations, Center for Technology Licensing at Weill Cornell Medicine (CTL @ WCM), BioVenture eLab, and the Daedalus Fund for Innovation.

Our team of best-in-class business development experts works collaboratively with a network of partners to commercialize biomedical technology. We provide a bridge between academic researchers and industry stakeholders, brokering engagements and alliances, engaging with and educating faculty about IP commercialization and business development—which includes patenting, licensing, and marketing—and developing entrepreneurial programming, education and mentoring.


$20M Gift to Boost Innovation in Health and Technology

December 8, 2022

A $20 million gift from Andrew H. ’71 and Ann R. Tisch will foster engagement and collaboration between Cornell Tech and Weill Cornell Medicine, catalyzing new discoveries at the...
Dr. Sheila Nirenberg Wins Barbara McClintock Women Innovator Award

June 17, 2022

Dr. Sheila Nirenberg, the Nanette Laitman Professor of Neurology and Neuroscience and a professor of physiology and biophysics at Weill Cornell Medicine, has received the Barbara...
2022 Biomedical Business Plan Challenge Showcases Promising Startups

June 3, 2022

A promising venture that hopes to develop a new drug therapy for colorectal cancer won $50,000 in funding and recognition from experienced venture capitalists on May 26 at the...